Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Vascular Surgery

Free Subscription Articles published in Lancet Retrieve available abstracts of 51 articles: HTML format Text format

Single Articles

January 2019
1. JOHANSSON M, Zahl PH, Siersma V, Jorgensen KJ, et al
   Screening for abdominal aortic aneurysm - Authors' reply.
   Lancet. 2019;393:28.
   PubMed     Text format    
   
   
   October 2018
2. GRAY WA, Keirse K, Soga Y, Benko A, et al
   A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial.
   Lancet. 2018;392:1541-1551.
   PubMed     Text format     Abstract available
   
   
   
3. ZERNA C, Thomalla G, Campbell BCV, Rha JH, et al
   Current practice and future directions in the diagnosis and acute treatment of ischaemic stroke.
   Lancet. 2018;392:1247-1256.
   PubMed     Text format     Abstract available
   
   
   
4. THE LANCET
   21st century management and prevention of stroke.
   Lancet. 2018;392:1167.
   PubMed     Text format    
   
   
   September 2018
5. VON BIRGELEN C, Zocca P, Buiten RA, Jessurun GAJ, et al
   Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt-chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, ran
   Lancet. 2018 Sep 21. pii: S0140-6736(18)32001.
   PubMed     Text format     Abstract available
   
   
   
6. PILGRIM T, Piccolo R, Heg D, Roffi M, et al
   Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial.
   Lancet. 2018;392:737-746.
   PubMed     Text format     Abstract available
   
   
   August 2018
7. VALGIMIGLI M, Frigoli E, Leonardi S, Vranckx P, et al
   Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
   Lancet. 2018 Aug 24. pii: S0140-6736(18)31714.
   PubMed     Text format     Abstract available
   
   
   
8. JEGER RV, Farah A, Ohlow MA, Mangner N, et al
   Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial.
   Lancet. 2018 Aug 24. pii: S0140-6736(18)31719.
   PubMed     Text format     Abstract available
   
   
   
9. VRANCKX P, Valgimigli M, Juni P, Hamm C, et al
   Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, ope
   Lancet. 2018 Aug 24. pii: S0140-6736(18)31858.
   PubMed     Text format     Abstract available
   
   
   
10. VLAAR APJ, Hunt BJ
    Improving peripheral intravenous catheter failure rates.
    Lancet. 2018;392:366-367.
    PubMed     Text format    
    
    
    
11. RICKARD CM, Marsh N, Webster J, Runnegar N, et al
    Dressings and securements for the prevention of peripheral intravenous catheter failure in adults (SAVE): a pragmatic, randomised controlled, superiority trial.
    Lancet. 2018;392:419-430.
    PubMed     Text format     Abstract available
    
    
    July 2018
12. DOWLING C, Firoozi S, Brecker S
    Percutaneous coronary intervention for stable angina in ORBITA.
    Lancet. 2018;392:28.
    PubMed     Text format    
    
    
    
13. FRANCIS DP, Al-Lamee R
    Percutaneous coronary intervention for stable angina in ORBITA - Authors' reply.
    Lancet. 2018;392:28-30.
    PubMed     Text format    
    
    
    
14. BANNING A, Redwood S
    Percutaneous coronary intervention for stable angina in ORBITA.
    Lancet. 2018;392:28.
    PubMed     Text format    
    
    
    
15. BAUER A, Rizas KD, Massberg S
    Percutaneous coronary intervention for stable angina in ORBITA.
    Lancet. 2018;392:27.
    PubMed     Text format    
    
    
    
16. REED GW, Kapadia SR
    Percutaneous coronary intervention for stable angina in ORBITA.
    Lancet. 2018;392:27-28.
    PubMed     Text format    
    
    
    
17. POCOCK SJ
    Percutaneous coronary intervention for stable angina in ORBITA.
    Lancet. 2018;392:26-27.
    PubMed     Text format    
    
    
    
18. BARAKAT MF, Simitsis P
    Percutaneous coronary intervention for stable angina in ORBITA.
    Lancet. 2018;392:26.
    PubMed     Text format    
    
    
    
19. TU T, Liu Q, Hu X, Zhou S, et al
    Percutaneous coronary intervention for stable angina in ORBITA.
    Lancet. 2018;392:25.
    PubMed     Text format    
    
    
    
20. MUTHALALY RG, Nerlekar N, Brown AJ
    Percutaneous coronary intervention for stable angina in ORBITA.
    Lancet. 2018;392:25-26.
    PubMed     Text format    
    
    
    
21. DEGRELL P, Picard F, Varenne O
    Percutaneous coronary intervention for stable angina in ORBITA.
    Lancet. 2018;392:25.
    PubMed     Text format    
    
    
    June 2018
22. IKEMURA N, Sawano M, Ueda I, Fukuda K, et al
    Consequence of reimbursement policy alteration for urgent PCI in Japan.
    Lancet. 2018;391:2208-2209.
    PubMed     Text format    
    
    
    May 2018
23. AZIZI M, Schmieder RE, Mahfoud F, Weber MA, et al
    Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.
    Lancet. 2018 May 22. pii: S0140-6736(18)31082.
    PubMed     Text format     Abstract available
    
    
    
24. JEGER RV, Mobius-Winkler S
    Stents in saphenous vein grafts.
    Lancet. 2018;391:1967-1968.
    PubMed     Text format    
    
    
    
25. BRILAKIS ES, Edson R, Bhatt DL, Goldman S, et al
    Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial.
    Lancet. 2018 May 11. pii: S0140-6736(18)30801.
    PubMed     Text format     Abstract available
    
    
    March 2018
26. ALKHALIL M
    Bioresorbable polymer drug-eluting stents.
    Lancet. 2018;391:936.
    PubMed     Text format    
    
    
    
27. KANDZARI DE, Mauri L, Koolen JJ, Doros G, et al
    Bioresorbable polymer drug-eluting stents - Authors' reply.
    Lancet. 2018;391:936-937.
    PubMed     Text format    
    
    
    
28. SHAH R
    Bioresorbable polymer drug-eluting stents.
    Lancet. 2018;391:935-936.
    PubMed     Text format    
    
    
    
29. HASSAGER C, Nagao K, Hildick-Smith D
    Out-of-hospital cardiac arrest: in-hospital intervention strategies.
    Lancet. 2018;391:989-998.
    PubMed     Text format     Abstract available
    
    
    
30. MOTOVSKA Z, Bhatt DL
    12 months of DAPT after acute coronary syndrome still beats 6 months.
    Lancet. 2018 Mar 9. pii: S0140-6736(18)30612.
    PubMed     Text format    
    
    
    
31. HAHN JY, Song YB, Oh JH, Cho DK, et al
    6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial.
    Lancet. 2018 Mar 9. pii: S0140-6736(18)30493.
    PubMed     Text format     Abstract available
    
    
    February 2018
32. BHATT DL
    CABG the clear choice for patients with diabetes and multivessel disease.
    Lancet. 2018 Feb 22. pii: S0140-6736(18)30424.
    PubMed     Text format    
    
    
    
33. HEAD SJ, Milojevic M, Daemen J, Ahn JM, et al
    Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.
    Lancet. 2018 Feb 22. pii: S0140-6736(18)30423.
    PubMed     Text format     Abstract available
    
    
    January 2018
34. BROWN DL, Redberg RF
    Last nail in the coffin for PCI in stable angina?
    Lancet. 2018;391:3-4.
    PubMed     Text format    
    
    
    
35. BICCARD BM, Madiba TE, Kluyts HL, Munlemvo DM, et al
    Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study.
    Lancet. 2018 Jan 3. pii: S0140-6736(18)30001.
    PubMed     Text format     Abstract available
    
    
    December 2017
36. DE WINTER RJ, Katagiri Y, Asano T, Milewski KP, et al
    A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 tri
    Lancet. 2017 Dec 1. pii: S0140-6736(17)33103.
    PubMed     Text format     Abstract available
    
    
    November 2017
37. AL-LAMEE R, Thompson D, Dehbi HM, Sen S, et al
    Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.
    Lancet. 2017 Nov 1. pii: S0140-6736(17)32714.
    PubMed     Text format     Abstract available
    
    
    October 2017
38. VARENNE O, Cook S, Sideris G, Kedev S, et al
    Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial.
    Lancet. 2017 Oct 31. pii: S0140-6736(17)32713.
    PubMed     Text format     Abstract available
    
    
    
39. BYRNE RA, Schuster T
    Biodegradable polymer drug-eluting stents: caveat emptor.
    Lancet. 2017;390:1814-1816.
    PubMed     Text format    
    
    
    September 2017
40. SPIERING W, Williams B, Van der Heyden J, van Kleef M, et al
    Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study.
    Lancet. 2017 Sep 1. pii: S0140-6736(17)32337.
    PubMed     Text format     Abstract available
    
    
    August 2017
41. SIBBING D, Aradi D, Jacobshagen C, Gross L, et al
    Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32155.
    PubMed     Text format     Abstract available
    
    
    April 2017
42. ALI ZA, Maehara A, Mintz GS, Stone GW, et al
    Optical coherence tomography-guided PCI - Authors' reply.
    Lancet. 2017;389:1608.
    PubMed     Text format    
    
    
    
43. SHAH R
    Optical coherence tomography-guided PCI.
    Lancet. 2017;389:1607.
    PubMed     Text format    
    
    
    November 2016
44. HERZEELE IV, Vermassen F
    Selection, technique, and follow-up: keys to success in EVAR.
    Lancet. 2016;388:2326-2328.
    PubMed     Text format    
    
    
    
45. PATEL R, Sweeting MJ, Powell JT, Greenhalgh RM, et al
    Endovascular versus open repair of abdominal aortic aneurysm in 15-years' follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial.
    Lancet. 2016;388:2366-2374.
    PubMed     Text format     Abstract available
    
    
    October 2016
46. FINN AV, Virmani R
    Biodegradable polymer drug-eluting stents: non-inferiority waiting for superiority?
    Lancet. 2016 Oct 28. pii: S0140-6736(16)32063.
    PubMed     Text format    
    
    
    
47. MACK M, Holmes DR
    Randomised trials in left main disease: a NOBLE effort.
    Lancet. 2016 Oct 28. pii: S0140-6736(16)32067.
    PubMed     Text format    
    
    
    
48. VON BIRGELEN C, Kok MM, van der Heijden LC, Danse PW, et al
    Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial.
    Lancet. 2016 Oct 28. pii: S0140-6736(16)31920.
    PubMed     Text format     Abstract available
    
    
    
49. ALI ZA, Maehara A, Genereux P, Shlofmitz RA, et al
    Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial.
    Lancet. 2016 Oct 28. pii: S0140-6736(16)31922.
    PubMed     Text format     Abstract available
    
    
    
50. MAKIKALLIO T, Holm NR, Lindsay M, Spence MS, et al
    Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.
    Lancet. 2016 Oct 28. pii: S0140-6736(16)32052.
    PubMed     Text format     Abstract available
    
    
    August 2016
51. REED GW, Rossi JE, Cannon CP
    Acute myocardial infarction.
    Lancet. 2016 Aug 5. pii: S0140-6736(16)30677.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: